E.E.S. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover E.e.s., and when can generic versions of E.e.s. launch?
E.e.s. is a drug marketed by Azurity and Arbor Pharms Llc and is included in four NDAs.
The generic ingredient in E.E.S. is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E.e.s.
A generic version of E.E.S. was approved as erythromycin ethylsuccinate by AZURITY on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for E.E.S.?
- What are the global sales for E.E.S.?
- What is Average Wholesale Price for E.E.S.?
Summary for E.E.S.
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 1,569 |
| Drug Prices: | Drug price information for E.E.S. |
| DailyMed Link: | E.E.S. at DailyMed |
Pharmacology for E.E.S.
| Drug Class | Macrolide Antimicrobial Macrolide |
| Physiological Effect | Decreased Sebaceous Gland Activity |
US Patents and Regulatory Information for E.E.S.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | E.E.S. | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | E.E.S. | erythromycin ethylsuccinate | TABLET, CHEWABLE;ORAL | 050297-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Arbor Pharms Llc | E.E.S. 200 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-002 | Aug 12, 1982 | BX | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Azurity | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
